Granulocytapheresis in the treatment of patients with rheumatoid arthritis

M Ohara, AR Saniabadi, S Kokuma, I Hirata… - Artificial …, 1997 - Wiley Online Library
The G‐1 column is an extracorporeal type granulocytapheresis device packed with 220 g
cellulose acetate beads to which granulocytes and monocytes specifically adhere. A total of …

Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1

J Fujimori, S Yoshino, M Koiwa, H Hirai… - Rheumatology …, 1996 - Springer
Patients with rheumatoid arthritis (RA) showed significantly (P< 0.01) increased numbers of
granulocytes in their peripheral blood compared with normal donors and patients with …

A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis

N Kashiwagi, I Hirata, R Kasukawa - Therapeutic Apheresis, 1998 - Wiley Online Library
Rheumatoid arthritis (RA) is an inflammatory condition, the etiology of which is not well
understood. Recent reports indicate a major role of granulocytes in the pathogenesis of RA; …

Clinical and basic studies on the G-1 column, a new extracorporeal therapeutic device effective in controlling rheumatoid arthritis

M Kyogoku, R Kasukawa - Inflammation Research, 1998 - Springer
The G-1 column, which is filled with cellulose acetate spherical beads of 2 mm diameter, is a
new type of extracorporeal perfusion device originally designed to remove granulocytes …

Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis

Y Ueki, S Yamasaki, Y Kanamoto, T Kawazu… - …, 2000 - academic.oup.com
Objectives. To evaluate the efficacy of filtration leucocytapheresis (LCP) for rheumatoid
arthritis (RA). Methods. LCP was carried out three times, with 1 week separating each …

Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study

M Nagashima, S Yoshino, H Tanaka, N Yoshida… - Rheumatology …, 1998 - Springer
To investigate if granulocyte and monocyte apheresis mitigates the symptoms of rheumatoid
arthritis (RA), and influences production of panmyelocytes (CD15+ CD16–cells) at the bone …

Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis

T Kondoh, Y Hidaka, H Katoh, N Inoue… - Artificial …, 1991 - Wiley Online Library
A practical on–line lymphocytapheresis (LCP) system using a leukapheresis filter
(Cellsorba, Asahi Medical Co.) was evaluated in six patients with refractory rheumatoid …

Advances in the use of therapeutic pheresis for the management of rheumatic diseases

DJ Wallace, D Goldfinger, R Thompson-Breton… - Seminars in Arthritis and …, 1980 - Elsevier
Twenty-two patients with rheumatoid arthritis, 3 with seronegative juvenile rheumatoid
arthritis, 4 with systemic lupus erythematosus, and 4 with psoriatic arthritis have undergone …

The mechanism of the efficiency of leukocytapheresis on rheumatoid arthritis

T Hidaka, K Suzuki - Therapeutic Apheresis, 1997 - Wiley Online Library
This study was designed to determine the efficacy of filtration leukocytapheresis (LCAP) in
the treatment of rheumatoid arthritis (RA) and the mechanism of its efficacy. Three filtration …

Plasmapheresis therapy in rheumatoid arthritis: a controlled, double-blind, crossover trial

IL Dwosh, AR Giles, PM Ford, JL Pater… - … England Journal of …, 1983 - Mass Medical Soc
Twenty-six patients with rheumatoid arthritis (average age, 57 years; average duration of
disease, 11 years) who were unresponsive to antiinflammatory and slow-acting …